ArticleFrontiers in pharmacology2022

Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial.

Xuan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.